PureIR / COMPANY BRIEFDATA AS OF 30 JUN 2026

HKEX · 01609.HK · MEDICAL DEVICES

Star Sports
Medicine

Sports-medicine solutions, from implants to surgical equipment.[1 p.11]

BiomaterialsImaging & powerSmart healthcareRegenerative medicine & tissue engineering
Revenue163.4Company disclosure [1 p.1]
Reported profit27.4Company disclosure [1 p.1]
Adjusted profit · non-IFRS48.9Company disclosure [1 p.1]

Adjusted profit adds back share-based awards and listing expenses. It supplements IFRS profit and is not a substitute for it. [1 p.17]

THE COMMERCIAL PICTURE

H1 2026 revenue · RMB million

Implants125.4
Equipment & consumables37.8

Selected segments; other income within revenue is excluded. [1 p.7]

FY revenue · audited · RMB million

FY2023238.5

FY2024327.1

FY2025402.8

[2 p.17]

READ WITH CONTEXT

RMB40.7m overseas revenueIn H1 2026, the overseas business represented 24.9% of revenue. Registrations and revenue measure different things. [1 p.10]

More than 3,000 hospitals in ChinaAt 30 June 2026. This is company-disclosed reach, not hospital purchasing or end-use volume. [1 p.10]

Context notes: PureIR synthesis from the cited disclosures.

KEEP THE RISKS IN VIEW

Procurement and distributor pricing pressure may affect selling prices and margins. Product defects, recalls and manufacturing disruption may create liabilities and damage reputation. [2 pp.42–43]